Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I H Patel

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|June 1, 1996
Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjectsK A Nieforth, R Nadeau, I H Patel, et al.
The New England Journal of Medicine|August 23, 1979
Hepatic failure from valproic acidT A Bowdle, I H Patel, A J Wilensky, et al.
Clinical Pharmacology and Therapeutics|January 1, 1984
Age and ceftriaxone kineticsJ R Luderer, I H Patel, J Durkin, et al.
Epilepsia|June 1, 1977
Efficacy testing of valproic acid compared to ethosuximide in monkey model: I. Dosage regimen design in the presence of diurnal oscillationsR H Levy, J S Lockard, I H Patel, et al.
Journal of Clinical Pharmacology|November 1, 1995
Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteersJ Zhi, A T Melia, H Eggers, et al.
Journal of Pharmaceutical Sciences|September 1, 1990
Synthesis and mechanisms of decomposition of some cephalosporin prodrugsA N Saab, A A Hussain, I H Patel, et al.
Journal of Pharmaceutical Sciences|August 1, 1977
Time-dependent kinetics III: diurnal oscillations in steady-state plasma valproic acid levels in rhesus monkeysR H Levy, J S Lockard, I H Patel, et al.
Clinical Pharmacology and Therapeutics|October 1, 1980
Valproic acid dosage and plasma protein binding and clearanceA T Bowdle, I H Patel, R H Levy, et al.
Journal of Pharmaceutical Sciences|October 1, 1980
Simultaneous analysis of phenobarbital and p-hydroxyphenobarbital in biological fluids by GLC-chemical-ionization mass spectrometryI H Patel, R H Levy, J M Neal, et al.
European Journal of Clinical Pharmacology|October 1, 1982
The influence of free fatty acids on valproic acid plasma protein binding during fasting in normal humansT A Bowdle, I H Patel, R H Levy, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|June 1, 1996
Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjectsK A Nieforth, R Nadeau, I H Patel, et al.
The New England Journal of Medicine|August 23, 1979
Hepatic failure from valproic acidT A Bowdle, I H Patel, A J Wilensky, et al.
Clinical Pharmacology and Therapeutics|January 1, 1984
Age and ceftriaxone kineticsJ R Luderer, I H Patel, J Durkin, et al.
Epilepsia|June 1, 1977
Efficacy testing of valproic acid compared to ethosuximide in monkey model: I. Dosage regimen design in the presence of diurnal oscillationsR H Levy, J S Lockard, I H Patel, et al.
Journal of Clinical Pharmacology|November 1, 1995
Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteersJ Zhi, A T Melia, H Eggers, et al.
Journal of Pharmaceutical Sciences|September 1, 1990
Synthesis and mechanisms of decomposition of some cephalosporin prodrugsA N Saab, A A Hussain, I H Patel, et al.
Journal of Pharmaceutical Sciences|August 1, 1977
Time-dependent kinetics III: diurnal oscillations in steady-state plasma valproic acid levels in rhesus monkeysR H Levy, J S Lockard, I H Patel, et al.
Clinical Pharmacology and Therapeutics|October 1, 1980
Valproic acid dosage and plasma protein binding and clearanceA T Bowdle, I H Patel, R H Levy, et al.
Journal of Pharmaceutical Sciences|October 1, 1980
Simultaneous analysis of phenobarbital and p-hydroxyphenobarbital in biological fluids by GLC-chemical-ionization mass spectrometryI H Patel, R H Levy, J M Neal, et al.
European Journal of Clinical Pharmacology|October 1, 1982
The influence of free fatty acids on valproic acid plasma protein binding during fasting in normal humansT A Bowdle, I H Patel, R H Levy, et al.
Pageof 7